Skip to content
Open access

In silico analysis of the defensive potential of dGTPases in Wolbachia against viral infections through a molecular docking study

Sep 2026 · Revista Colombiana de Ciencias Químico Farmacéuticas · Vol 55, pp. 721-737 · 0 citations · 33 references

TL;DR

The Wolbachia dGTPase suggests a structural specialization that makes it particularly efficient in dGTP binding, suggesting a role in dNTP depletion as an antiviral mechanism.

Abstract

Introduction: Wolbachia is an endosymbiont that protects its host against viral infections, although the underlying mechanisms remain unclear. This in silico study explores the presence of antiviral defense systems in Wolbachia, with emphasis on dGTPases, enzymes that degrade dGTP, an essential nucleotide for viral replication. Methodology: Using PADLOC and DefenseFinder, 194 complete Wolbachia genomes were analyzed and defense systems were identified. The structures of dGTPases from Wolbachia, R. felis, S. putrefaciens and E. coli were predicted with Protenix and docked with dGTP using HADDOCK 2.4. Interactions were characterized with PLIP, affinity with PRODIGY‑LIG, and in silico mutagenesis was performed in E. coli. Results: The dGTPase system is present in 99% of strains carrying defense systems. The Wolbachia dGTPase showed the best HADDOCK score (-30.2), a very negative electrostatic energy (-128.1 kcal/mol) and a compact Mn²⁺ coordination (square planar, distances ≤2.44 Å) with three salt bridges. R. felis presented a similar score (-29.2) but a lower electrostatic component (-44.9 kcal/mol). The free‑living dGTPases (S. putrefaciens and E. coli) showed less favorable scores (-22.3 and -21.5). Mutagenesis (Phe391→Tyr, Glu400→Met) in E. coli did not reproduce the high affinity of Wolbachia. Conclusion: The Wolbachia dGTPase suggests a structural specialization that makes it particularly efficient in dGTP binding, suggesting a role in dNTP depletion as an antiviral mechanism.

Read PDF

Similar papers

Aug 2026

Computational insights into the inhibitory potential of cyclotides Psyle B and Psyle C against key surface proteins of avian influenza H5N1.

This study explored cyclotide-based drug design against H5N1 using computational approaches and revealed that Psyle B and Psyle C exhibited strong interactions with HA and NA, highlighting Psyle B and Psyle C as promising antiviral leads.

S. Altaf, Kainat Sarwar, Rao Zahid Abbas et al. · 0 citations
Open access 2026

Bioinformatic Prediction of Cellular Targets of Aminoestrones through Molecular Docking: Implications for Flavivirus Replication and Cell-to-Cell Transmission.

Background: Flaviviruses such as dengue virus and Zika virus rely on host cellular factors to complete their replication cycle. Host proteins involved in cytoskeleton dynamics and vesicular trafficking may represent potential therapeutic targets. Bioactive aminoestrones have shown antiviral activity, although their mol...

Ednner E. Victoria-Blanco, Lydier De Gracia · 0 citations
Open access Sep 2026

The scorpion peptide Eval418 inhibits duck Tembusu virus replication by disrupting viral structure and early-stage infection

Introduction Duck Tembusu virus (DTMUV) causes egg-drop syndrome and neurological symptoms in ducks, resulting in significant economic losses. Currently, no specific antiviral drugs are available for DTMUV infection. Scorpion-derived peptides have emerged as promising lead compounds for antiviral drug development. In t...

Yu-Ting Cheng, Qi Feng, Pei Zhang et al. · 0 citations
Open access Sep 2026

Characterization of Novel Mycobacteriophages of Subcluster A3: Evolutionary Plasticity of the Lysogeny Module and Lytic Potential

Findings highlight lysogeny module plasticity in closely related phages and position Cat, with its naturally occurring repressor deletion and potent lytic activity, as a promising candidate against drug-resistant tuberculosis.

M. Zaychikova, Maja Malakhova, S. Kuznetsova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.